Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. - Wikidata - awgldk - TriplyDB

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

http://www.wikidata.org/entity/Q35845900

about

Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015 Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.Meningococcal disease and the complement system.Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines Prevalence and phase variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitidis.A decade of invasive meningococcal disease surveillance in Poland.Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences.Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012.Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage Underestimation of Invasive Meningococcal Disease in Italy.The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?Invasive meningococcal disease in elderly people, New South Wales, Australia, 1993 to 2012.Hexa-acylated lipid A is required for host inflammatory response to Neisseria gonorrhoeae in experimental gonorrhea Neisseria meningitidis serogroup W, Burkina Faso, 2012.Advances with vaccination against Neisseria meningitidis.Meningococcal vaccines: current issues and future strategies.An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.Genomic Analysis of Serogroup Y Neisseria meningitidis Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms.The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.Rise in Group W Meningococcal Carriage in University Students, United Kingdom.Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013.Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.Neisseria adhesin A variation and revised nomenclature scheme.Vaccination strategies for the prevention of meningococcal disease.

P2860

Q28554935-49400C6C-8616-4613-A689-E1B9A2642983 Q33743483-D1E66802-9945-45E4-BF03-319D23CE0428 Q34376170-BFDB267F-42CA-408A-B19B-63C3AEA7B536 Q34707962-0F0B7AFF-5FD2-435D-8998-DC14A63CD3B3 Q34792516-D0598202-5413-4AC6-9E42-74E22FC53E7F Q34921091-9A89AF47-3135-42CB-90A2-E8A1BD7E49AB Q34972731-719E6EDD-3FEA-49F0-9A95-E268322987C9 Q35006862-52CBAD6D-57A0-477F-B914-BD4C9DFAAF31 Q35137074-65519BE6-CC46-43CF-8B0D-E1666D4FEC99 Q35757635-BC2F2B76-5CEF-4FA5-A0CA-D5C5D7425E01 Q35826786-94125B5F-3451-46D4-BA5B-A67D23D46AB3 Q35865540-6B526ED8-BD8F-4A37-8A80-69754AD6E668 Q35865898-F1CC5FBD-1B52-459A-8017-FE14D4A58FC4 Q36617054-D9ED7CA3-06D8-4E64-ADF4-8516AF402E17 Q37037419-FD08E531-DF5A-4FB0-8989-CE6EC3371583 Q37517971-42E50868-4026-46B6-80F0-9567B8768E9B Q37548187-5E92E6DD-F788-432A-B9F1-FD53811463E4 Q37621672-E329B05D-79DE-4CDA-8F0F-6983750C5E99 Q38040527-7C72401E-8CA5-4CE5-9C25-6CF1DDE3C8C2 Q38120493-274E6D37-42A5-4D9B-9138-DBFAA3AABF48 Q38775024-A49910D4-0965-406D-9F16-C93443DB97F9 Q40126952-6E4869AE-33F0-4A21-B260-BB40EA8CC237 Q40179042-4F3C1A89-736C-4BB4-BB44-DCA79016E2FC Q40197164-4790DE67-618A-4017-B08A-926689A5F97A Q40783765-A537DE3C-38C0-4152-80F8-E330A28D8DA8 Q40895395-B9CD2350-64A6-4309-9862-5E17DE675B97 Q41666578-F4ED2353-1976-4369-907C-98A9120874DE Q42735385-5F7D3AB8-EEEB-4A43-B287-C36347B05232 Q54964676-79A1E4C4-A882-498B-805A-8D61D4BF4C99

P2860

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

http://www.wikidata.org/entity/Q35845900

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@ast

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@en

type

label

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@ast

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@en

prefLabel

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@ast

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@en

P1433

Q35845900-75CCD852-EF2F-4980-AA28-B31CF0D5A4DF

P1476

Q35845900-D53DAE9C-0A6E-47A9-ADDD-BFB590D666EF

P2093

Q35845900-23969E84-6762-46A7-8A9E-3F9BE8DF2BE3

Q35845900-3FBB5774-6AC3-47C7-BB8C-F3B22AE6FFD8

Q35845900-67BE692F-5A95-4392-891F-65DF9AB4DE73

Q35845900-84F4DE15-7477-4103-9AAC-DDB79E4101BE

Q35845900-8EA1E324-7436-4DE9-BCBD-324F4040DF4A

Q35845900-91338E37-4176-4D69-B598-BAEF1DD68993

Q35845900-9A387C5C-74F8-4503-B858-CA004DFFC1EA

Q35845900-BCB1785D-873F-421B-965D-62D768A30A3B

Q35845900-ED7AED7C-C937-4ECD-B5A3-9C9E61FF1AA5

P2860

Q35845900-001A600A-F30F-4F97-A4D0-32D2F7A95E1A

Q35845900-0234BE3E-F158-46B6-ABBB-4ECBD692129F

Q35845900-0AA3DC82-888E-400D-9CB1-D58A11723A0C

Q35845900-11B171A4-5385-4D14-98F4-F25023DC38FE

Q35845900-1EF38AD8-7505-4398-BA2B-94F6D717DD33

Q35845900-24180BA7-FB6F-4CD7-BEAA-9C656A7B7F3D

Q35845900-25BC8358-DF78-445D-A857-A22C45B6935F

Q35845900-27C56F04-8CF6-40F2-A279-D2659CDC50A2

Q35845900-33696994-B46B-4071-A9E4-E855E4ED7561

Q35845900-4F62B636-0BD0-43A9-B235-019BFED59E2A

P304

Q35845900-83C5BAA9-B09F-4AE8-8C00-094B037BBA8D

P31

Q35845900-70C14B36-4B6C-4402-895E-68DB9926873D

P356

Q35845900-17FBECF0-F1D0-4C78-B7BA-D574ED2920C2

P433

Q35845900-EE652C03-7A94-4A0B-9C8A-6D0C2B2E80D4

P478

Q35845900-D508A83E-565F-4693-91AE-D953F1429F17

P577

Q35845900-1917F57C-B4EB-491E-A73B-AA731D2303C3

P5875

Q35845900-9D619FA6-67DC-4732-9327-A29A7EAEDC00

P698

Q35845900-FDF3FF31-0FB5-4694-A621-A819FF6C0D90

P932

Q35845900-AACC0334-13D1-4FB0-BA56-76CD4FE16726

P356

P1433

Emerging Infectious Diseases

P1476

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

@en

P2093

Anthony D Carr

http://www.w3.org/2001/XMLSchema#string

Edward B Kaczmarski

http://www.w3.org/2001/XMLSchema#string

Jamie Findlow

http://www.w3.org/2001/XMLSchema#string

Jay Lucidarme

http://www.w3.org/2001/XMLSchema#string

Lynne S Newbold

http://www.w3.org/2001/XMLSchema#string

Mary E Ramsay

http://www.w3.org/2001/XMLSchema#string

Raymond Borrow

http://www.w3.org/2001/XMLSchema#string

Shamez N Ladhani

http://www.w3.org/2001/XMLSchema#string

Stephen J Gray

http://www.w3.org/2001/XMLSchema#string

P2860

NadA, a novel vaccine candidate of Neisseria meningitidis

Clinical features and outcome of sporadic serogroup W135 disease Taiwan.

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy

Cationic antimicrobial peptide resistance in Neisseria meningitidis.

Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.

Meningococcal pneumonia: characterization and review of cases seen over the past 25 years.

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1801.110901

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221762611

http://www.w3.org/2001/XMLSchema#string

P698

22261040

http://www.w3.org/2001/XMLSchema#string

P932

3310110

http://www.w3.org/2001/XMLSchema#string